Identification of Galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain

Cancer Investigation

Volumn 26, Issue 6, 2008, Pages 615-623

  Mayoral, M A ^a   Mayoral, C ^b   Meneses, A ^c   Villalvazo, L ^d   Guzman, A ^d   Espinosa, B ^e   Ochoa, J L ^f   Zenteno, E ^g   Guevara, J ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^f CENTRO DE INVESTIGACIONES BIOLÓGICAS DEL NOROESTE   (Mexico)

^g UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Breast cancer; Galectin 3; Lectin; Metastasis; Mucins; O glycosylation; T antigen

Indexed keywords

AGGLUTININ; GALECTIN 3; GLYCAN DERIVATIVE; LECTIN; MUCIN;

ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER GROWTH; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION;

ARACHIS HYPOGAEA; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; GALECTIN 3; GLYCOPROTEINS; GLYCOSYLATION; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; MUCINS; NEURAMINIDASE; PLANT LECTINS; SPECIMEN HANDLING; TRYPSIN; UP-REGULATION;

EID: 46349087300     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701837051     Document Type: Article

References (56)

1. Hakomori, S. Glycosylation defining cancer malignancy: New wine in an old bottle. PNAS 2002, 99, 10231-10233.
2. Couldrey, C.; Green, J.E. Metastases: the glycan connection. Breast Cancer Res 2000, 2, 321-323.
3. Springer, G.F.; Desai, P.R.; Ghazizadeh, M.; Tegmeyer, H. T/Tn pancarcinoma autoantigens: fundamental, diagnostic and prognostic aspects. Cancer Detect Prev 1995, 19, 173-182.
4. Springer, G.F. T and Tn pancarcinoma markers: autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma-detection, and long-term breast carcinoma immunotherapy. Crit Rev Oncogen 1995, 6, 57-85.
5. Van den Steen, P.; Rudd, P.M.; Dwek, R.A.; Openakker, G. Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol 1998, 33, 151-208.
6. Martensson, S; Levery, S.B.; Fang, T.T.; Bendiak, B. Neutral core oligosaccharides of bovine submaxillary mucin: use of lead tetraacetate in the cold for establishing branch positions. Eur J Biochem 1998, 258, 603-622.
7. Fonseca, I.; Costa Rosa, J.; Felix, A. Therkildsen, M.H.; Soares, J. Simple mucin-type carbohydrate antigens (T, Tn, and sialosyl-Tn) in mucoepidermoid carcinoma of the salivary glands. Histopathol 1994, 25, 537-543.
8. Cao, Y.; Stosiek, P.; Springer, G.F.; Karsten, U. Thomsen Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem. Cell Biol 1996, 106, 197-207.
9. Glinsky, V.V.; Huflejt, M.E.; Glinsky, G.V.; Deutscher, S.L.; Quinn, T.P. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on β-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res 2000, 60, 2584-2588.
10. Lis, H.; Sharon, N. Lectins as molecules and as tools. Ann Rev Biochem 1986, 55, 35-67.
11. Raz, A.; Lotan, R. Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev 1987, 6, 433-452.
12. Zou, J.; Glinsky, V.V.; Landon, L.A.; Matthews, L.; Deutscher, S.L. Peptides specific to the Galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogen 2005, 26, 309-318.
13. Shigeoka, H.; Karsten, U.; Okuno, K.; Yasutomi, M. Inhibition of liver metastases from neuraminidase-treated colon 26 cells by an anti-Thomsen- Friedenreich-specific monoclonal antibody. Tumour Biol 1999, 20, 139-146.
14. Takenaka, Y.; Fukumori, T.; Raz, A. Galectin-3 and metastasis. Glycoconj J 2004, 19, 453-549.
15. Le Marer, N.; Hughes, R.C. Effects of the carbohydrate-binding protein Galectin-3 on the invasiveness of human breast carcinoma cells. J Cell Physiol 1996, 168, 51-58.
16. Matarrese, P.; Fusco, O.; Tinari, N.; Natoli, C.; Ciu, F.T.; Semeraro, M.L.; et al. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer 2000, 85, 545-554.
17. Zenteno, E.; Ochoa, J.L. Isolation and purification of Amaranthus leucocarpus lectin on stroma column. Phytochem 1988, 27, 313-317.
18. Zenteno, E.; Debray, H.; Montreuil, J. Purification and partial characterization of two lectins from the cactus Machaerocereus eruca. FEBS Letters 1988, 238, 95-100.
19. Savage, D.; Mattson, G.; Desai, S.; Nielander, G.; Morgensen, S.; Conklin, E. eds. Avidin-biotin chemistry: A handbook. Ed. Pierce Chemical Company, Rockford, IL, USA. 1992.
20. Guevara, J.; Espinosa, B.; Zenteno, E.; Vasquez, L.; Luna, J.; Perry, G.; Mena, R. Altered glycosylation pattern in Alzheimer disease. J Neuropathol Exp Neurol 1998, 57, 905-914.
21. American Cancer Society: Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society. 2007.
22. Steeg, P.S. Molecular biology of breast cancer metastasis 'Has it spread?': disarming one of the most terrifying questions. Breast Cancer Res 2000, 2, 396-399.
23. Hsiung, R.; Zhu, W.; Klein, G.; Qin, W.; Rosenberg, A.; Park, P. et al. High basic fibroblast growth factors levels in nipple aspirate fluid are correlated with breast cancer. Cancer J 2002, 8, 303-310.
24. Foretova, L.; Garber, J.E.; Sadowsky, N.L.; Verselis, S.J.; Joseph, D.M. Andrade, A.F.F. et al. Carcinoembryonic antigen in breast nipple aspirate fluid. Cancer Epidem Biom Prev 1998, 7, 195-198.
25. Kumar, S.R.; Sauter, E.R.; Quinn, T.P.; Deutscher, S.L. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection. Clin Cancer Res 2005, 11, 6868-6871.
26. Hernandez, P.; Tetaert, D.; Vergoten, G.; Debray, H.; del Carmen Jimenez, M.; Fernandez, G.; Agundis, C.; et al. Specificity of Amaranthus leucocarpus syn. hypocondriacus lectin for O-glycopeptides. Biochim Biophys Acta 2004, 1674, 282-290.
27. Yuan, M.; Itzkowitz, S.H.; Boland, C.R.; Kim, Y.D.; Tomita, J.T.; Palekar, A.; et al. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res 1986, 46, 4841-4847.
28. Irazoqui, F.J.; Jansson, B.; Lopez, P.H.H.; Nores, G.A. Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation. J Biochem 2001, 130, 33-37.
29. Wang, B.L.; Springer, G.F.; Carlstedt, S.C. Quantitative computerized image analysis of Tn and T (Thomsen-Friedenreich) epitopes in prognostication of human breast carcinoma. J Histochem Cytochem 1997, 45, 1393-1400.
30. Baldus, S.E.; Zirbes, T.K.; Hanisch, F.G.; Kunze, D.; Shafizadeh, S.T.; Nolden, S. et al. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma. A clinicopathologic study of 264 patients. Cancer 2000, 88, 1536-1543.
31. Cao, Y.; Karsten, U.; Otto, G.; Bannasch, P. Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha 2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Virchows Archiv 1999, 434, 503-509.
32. Schindlbeck, C.; Jeschke, U.; Schulze, S.; Karsten, U.; Janni, W.; Rack B. et al. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients. Breast Cancer Res Treat 2007, 101, 17-25.
33. Lotan, R.; Skutelsky, E.; Danon, D.; Sharon, N. The purification, composition and specificity of the anti-T lectin from peanut (Arachis hypogaea). J Biol Chem 1975, 250, 8518-8523.
34. Zenteno, E.; Vazquez, L.; Chavez, R.; Cordoba, F.; Wieruszeski, J.M.; Montreuil, J.; Debray, H. Specificity of the isolectins from the plant cactus Machaerocereus eruca for oligosaccharides from porcine stomach mucin. Glycoconj J 1995, 12, 699-706.
35. Laferte, S.; Chan, N.W.; Sujino, K.; Lowary, T.L.; Palcic, M.M. Intracellular inhibition of blood group A glycosyltransferase. Eur J Biochem 2000, 267, 4840-4849.
36. Meromzky, L.; Lotan, R.; Raz, A. Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization. Cancer Res 1986, 46, 5270-5275.
37. Pacis, R.A.; Pilat, M.J.; Pienta, K.J.; Wojno, K.; Raz, A.; Hogan, V.; Cooper, C.R. Decreased galectin-3 expression in prostate cancer. Prostate 2000, 44, 118-123.
38. Lotz, M.M.; Andrews Jr., C.W.; Korzelius, C.A.; Lee, E.C.; Steele Jr., G.D.; Clarke, A.; Mercurio, A.M. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. PNAS 1993, 90, 3466-3470.
39. Castronovo, V.; Campo, E.; van den Brule, F.A.; Claysmith, A.P.; Cioce, V.; Liu, F.T.; Fernandez, P.L.; Sobel, M.E. Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. J Natl Cancer Inst 1992, 84, 1161-1169.
40. Castronovo, V.; van den Brule, F.A.; Jackers, P.; Clausse, N.; Liu, F.T.; Gillet, C.; Sobel, M.E. Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 1996, 179, 43-48.
41. Idikio, H. Galectin-3 expression in human breast carcinoma: correlation with cancer histologic grade. Int J Oncol 1998, 12, 1287-1290.
42. Nangia-Makker, P.; Thompson, E.; Hogan, C.; Ochieng, J.; Raz, A. Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell-line. Int J Oncol 1995, 7, 1079-1087.
43. Honjo, Y.; Nangia-Makker, P.; Inohara, H.; Raz, A. Down regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 2001, 7, 661-668.
44. Bresalier, R.S.; Mazurek, N.; Sternberg, L.R.; Byrd, J.C.; Yunker, C.K.; Nangia-Makker, P.; Raz, A. Metastasis of human colon cancer is altered by modifying expression of the β-galactose-binding protein galectin-3. Gastroenterology 1998, 115, 287-296.
45. Meyer, J.S. Cell kinetics of histologic variants of in situ breast carcinoma. Breast Cancer Res Treat 1986, 7, 171-180.
46. Lagios, M.D.; Westdahl, P.R.; Margolin, F.R.; Rose, M.R. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982, 50, 1309-1314.
47. Nangia-Makker, P.; Sarvis, R.; Visscher, D.W.; Bailey-Penrod, J.; Raz, A.; Sarkar, F.H. Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Res Treat 1998, 49, 171-183.
48. Le Marer, N.; Hughes, R.C. Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells. J Cell Physiol 1996, 168, 51-58.
49. Shekhar, M.P.V.; Nangia-Makker, P.; Tait, L.; Miller, F.; Raz, A. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions. Am J Pathol 2004, 165, 1931-1941.
50. Baptiste, T.A.; James, A.; Saria, M.; Ochieng, J. Mechanotransduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin. Exp Cell Res 2007, 313, 652-664.
51. Song, Y.K.; Billiar, T.R.; Lee, Y.J. Role of galectin-3 in breast cancer metastasis. Involvement of Nitric Oxide. Am J Pathol 2002, 160, 1069-1075.
52. Hsu, D.K.; Dowling, C.A.; Jeng, K.C.; Chen, J.T.; Yang, R.Y.; Liu, F.T. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 1999, 17, 519-526.
53. Hoyer, K.K.; Pang, M.; Gui, D.; Shintaku, I.P.; Kuwabara, I.; Liu, F.T.; Said, J.W.; Baum, L.G.; Teitell, M.A. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. Am J Pathol 2004, 164, 893-902.
54. Glinsky, V.V.; Glinsky, G.V.; Rittenhouse-Olson, K.; Huflejt, M.E.; Glinskii, O.V.; Deutscher, S.L.; Quinn, T.P. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 2001, 61, 4851-4857.
55. Hanisch, F.G. O-glycosylation of the mucin-type. Biol Chem 2001, 382, 143-149.
56. Pratt, M.R.; Hang, H.C.; Ten Hagen, K.G.; Rarick, J.; Gerken, T.A.; Tazbak, L.A.; Berotozzi, C.R. Deconvoluting the functions of polypeptide N-alpha-acetylgalactosaminyltransferase family members by glycopeptide substrate profiling. Chem Biol 2004, 11, 1009-1116.